$35.70
-11.36% past month
Notable price movement
Sep 15, 2026
$35.64-2.99%
Shares fell 2.99%, a move not shared by the broad market, which was roughly flat with the S&P 500 ETF down just 0.46% .
Sep 14, 2026
$36.74-8.38%
Shares fell 8.38%, a decline far steeper than the broad market, with the S&P 500 ETF down only 0.45% the same session .
Sep 11, 2026
$40.10+7.28%
Super Micro was reported to have booked over $60 billion in Q4 orders while guiding FY2027 revenue to $65-72 billion, according to Seeking Alpha . The stock's 7.28% gain came alongside a broad-market move of only 0.85% for the S&P 500 ETF (SPY), meaning the move was not shared by the broader market .
Sep 10, 2026
$37.38-3.98%
Super Micro shares fell 3.98% on a day when the broad market was little changed, with the S&P 500 ETF down 0.60%, so the decline was not shared by the broader market . Trading volume was well below the trailing average at 0.5x, with shares ranging between 37.37 and 39.26 .
Sep 9, 2026
$38.93-3.30%
The Motley Fool reported that Super Micro Computer disclosed an insider sale of company shares worth $7.7 million . Shares fell 3.30% that day while the S&P 500 moved -0.46%, so the decline was not shared by the broad market . Trading volume was below the trailing average, with the session ranging between 38.84 and 40.18 .
Sep 8, 2026
$40.26+1.69%
Shares rose 1.69% the same day 24/7 Wall St reported that AI server stocks, including Super Micro and Hewlett Packard Enterprise, were advancing on a margin beat that management had already acknowledged would be temporary during an earnings call .
Sep 4, 2026
$39.59+4.54%
Shares rose 4.54% while the broad market, as measured by the S&P 500 ETF, slipped 0.39% the same session, indicating the move was not shared by the wider market .
Closing prices for SMCI. Summaries describe past sessions only and are not advice, a forecast or a recommendation.
Recent news
Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.
Prices and financial data are historical and provided for research only. Not investment advice.